Wesbanco Bank Inc Catalyst Pharmaceuticals, Inc. Transaction History
Wesbanco Bank Inc
- $3.29 Billion
- Q2 2025
A detailed history of Wesbanco Bank Inc transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Wesbanco Bank Inc holds 56,000 shares of CPRX stock, worth $1.2 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
56,000
Previous 19,000
194.74%
Holding current value
$1.2 Million
Previous $469,000
159.06%
% of portfolio
0.04%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding CPRX
# of Institutions
385Shares Held
99.7MCall Options Held
37KPut Options Held
20.5K-
Black Rock Inc. New York, NY18.7MShares$401 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.5MShares$182 Million0.0% of portfolio
-
State Street Corp Boston, MA5.53MShares$119 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.42MShares$73.4 Million2.1% of portfolio
-
Goldman Sachs Group Inc New York, NY3.14MShares$67.3 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.21B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...